Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$36.71 - $44.15 $1.22 Million - $1.47 Million
-33,335 Reduced 17.96%
152,305 $6.33 Million
Q1 2023

May 15, 2023

SELL
$36.81 - $48.12 $31,767 - $41,527
-863 Reduced 0.46%
185,640 $7.67 Million
Q4 2022

Feb 14, 2023

BUY
$35.68 - $44.71 $2.68 Million - $3.36 Million
75,155 Added 67.5%
186,503 $7.69 Million
Q3 2022

Nov 14, 2022

SELL
$42.51 - $54.02 $9,267 - $11,776
-218 Reduced 0.2%
111,348 $4.88 Million
Q2 2022

Aug 22, 2022

BUY
$46.84 - $59.75 $11,663 - $14,877
249 Added 0.22%
111,566 $5.49 Million
Q1 2022

May 16, 2022

SELL
$48.09 - $57.79 $32,364 - $38,892
-673 Reduced 0.6%
111,317 $6.31 Million
Q4 2021

Feb 14, 2022

BUY
$47.19 - $62.68 $40,205 - $53,403
852 Added 0.77%
111,990 $5.88 Million
Q3 2021

Nov 15, 2021

BUY
$56.91 - $67.81 $553,335 - $659,316
9,723 Added 9.59%
111,138 $6.65 Million
Q2 2021

Aug 12, 2021

SELL
$64.02 - $71.72 $1.67 Million - $1.87 Million
-26,130 Reduced 20.49%
101,415 $6.87 Million
Q1 2021

May 17, 2021

BUY
$53.26 - $68.08 $142,257 - $181,841
2,671 Added 2.14%
127,545 $8.36 Million
Q4 2020

Feb 12, 2021

BUY
$43.41 - $56.51 $243,139 - $316,512
5,601 Added 4.7%
124,874 $7.04 Million
Q3 2020

Nov 13, 2020

SELL
$47.43 - $60.75 $71,477 - $91,550
-1,507 Reduced 1.25%
119,273 $5.79 Million
Q2 2020

Aug 14, 2020

SELL
$43.51 - $66.59 $32,197 - $49,276
-740 Reduced 0.61%
120,780 $6.72 Million
Q1 2020

May 14, 2020

SELL
$32.82 - $81.13 $107,485 - $265,700
-3,275 Reduced 2.62%
121,520 $6.16 Million
Q4 2019

Feb 13, 2020

BUY
$60.96 - $77.7 $396,849 - $505,827
6,510 Added 5.5%
124,795 $9.65 Million
Q3 2019

Nov 13, 2019

BUY
$55.78 - $68.08 $58,178 - $71,007
1,043 Added 0.89%
118,285 $7.5 Million
Q2 2019

Aug 14, 2019

BUY
$53.69 - $65.47 $3.04 Million - $3.71 Million
56,671 Added 93.56%
117,242 $6.86 Million
Q1 2019

May 15, 2019

BUY
$44.53 - $58.9 $210,849 - $278,891
4,735 Added 8.48%
60,571 $3.44 Million
Q4 2018

Feb 15, 2019

BUY
$47.64 - $71.26 $140,395 - $210,003
2,947 Added 5.57%
55,836 $2.77 Million
Q3 2018

Nov 20, 2018

SELL
$52.03 - $71.41 $7,336 - $10,068
-141 Reduced 0.27%
52,889 $3.75 Million
Q2 2018

Aug 10, 2018

BUY
$48.15 - $56.68 $57,876 - $68,129
1,202 Added 2.32%
53,030 $2.76 Million
Q1 2018

May 17, 2018

BUY
$46.03 - $61.28 $242,025 - $322,210
5,258 Added 11.29%
51,828 $2.71 Million
Q4 2017

Feb 13, 2018

BUY
$50.58 - $60.79 $2.36 Million - $2.83 Million
46,570
46,570 $2.73 Million

Others Institutions Holding NUVA

About NUVASIVE INC


  • Ticker NUVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 52,061,000
  • Description
  • NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal impl...
More about NUVA
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.